Back
MoonLake Immunotherapeutics Stock Price Chart
Still Time to Get In: RAD Intel at $0.85/Share
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Sell
46
MLTX
MoonLake Immunotherapeutics
Last Price:
$14.89
Seasonality Move:
19.6%
7 Day Trial
ALL ACCESS PASS
$
7
This AI Layer Just Raised Its Share Price
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi-
The current trend is relatively stagnant and MLTX is experiencing selling pressure, which indicates risk of future bearish movement.
MoonLake Immunotherapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 13.77 | Buy |
| 20-day SMA: | 13.01 | Buy |
| 50-day SMA: | 11.84 | Buy |
| 200-day SMA: | 37.26 | Sell |
| 8-day EMA: | 13.86 | Buy |
| 20-day EMA: | 13.3 | Buy |
| 50-day EMA: | 17.78 | Sell |
| 200-day EMA: | 34 | Sell |
MoonLake Immunotherapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.07 | Sell |
| Relative Strength Index (14 RSI): | 57.32 | Buy |
| Chaikin Money Flow: | -953414 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (11.01 - 13.91) | Buy |
| Bollinger Bands (100): | (11.15 - 55.17) | Sell |
MoonLake Immunotherapeutics Technical Analysis
| Nov 21 | Nov 24 | Nov 25 | Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 21 | 24 | 25 | 26 | 28 | 01 | 02 | 03 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for MoonLake Immunotherapeutics Stock
Is MoonLake Immunotherapeutics Stock a Buy?
-
MoonLake Immunotherapeutics share price is 14.90 while MLTX 8-day simple moving average is 13.77, which is a Buy signal.
-
The stock price of MLTX is 14.90 while MoonLake Immunotherapeutics 20-day SMA is 13.01, which makes it a Buy.
-
MoonLake Immunotherapeutics 50-day simple moving average is 11.84 while MLTX share price is 14.90, making it a Buy technically.
-
MLTX stock price is 14.90 and MoonLake Immunotherapeutics 200-day simple moving average is 37.26, creating a Sell signal.
MLTX Technical Analysis vs Fundamental Analysis
Sell
46
MoonLake Immunotherapeutics (MLTX)
is a Sell
Is MoonLake Immunotherapeutics a Buy or a Sell?
-
MoonLake Immunotherapeutics stock is rated a SellThe current MoonLake Immunotherapeutics [MLTX] share price is $14.90. The Score for MLTX is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
MoonLake Immunotherapeutics Stock Info
Market Cap:
1.1B
Price in USD:
14.90
Share Volume:
1.3M
MoonLake Immunotherapeutics 52-Week Range
52-Week High:
62.75
52-Week Low:
5.95
Sell
46
MoonLake Immunotherapeutics (MLTX)
is a Sell
MoonLake Immunotherapeutics Share Price Forecast
-
What is the MoonLake Immunotherapeutics stock price today?The MoonLake Immunotherapeutics stock price is 14.90 USD today.
-
Will MLTX stock go up or go down?MoonLake Immunotherapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is MoonLake Immunotherapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, MoonLake Immunotherapeutics is overvalued.
Is MoonLake Immunotherapeutics Stock a Buy?
-
MoonLake Immunotherapeutics share price is 14.90 while MLTX 8-day exponential moving average is 13.86, which is a Buy signal.
-
The stock price of MLTX is 14.90 while MoonLake Immunotherapeutics 20-day EMA is 13.30, which makes it a Buy.
-
MoonLake Immunotherapeutics 50-day exponential moving average is 17.78 while MLTX share price is 14.90, making it a Sell technically.
-
MLTX stock price is 14.90 and MoonLake Immunotherapeutics 200-day simple moving average is 34.00, creating a Sell signal.
Fundamental Analysis of MoonLake Immunotherapeutics
Is MoonLake Immunotherapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.86 per share, and a decrease next year of $0.00 per share.
Technical Analysis of MoonLake Immunotherapeutics
Should I short MoonLake Immunotherapeutics stock?
-
MLTX Moving Average Covergence Divergence (MACD) indicator is -0.07, suggesting MoonLake Immunotherapeutics is a Sell
-
MoonLake Immunotherapeutics Relative Strength Index (RSI) is 57.32, which suggest MoonLake Immunotherapeutics is overbought
-
The Bollinger Bands (25) for MoonLake Immunotherapeutics is (11.01 - 13.91), which suggest MoonLake Immunotherapeutics is a Sell
-
The Bollinger Bands (100) for MoonLake Immunotherapeutics is (11.15 - 55.17), which suggest MoonLake Immunotherapeutics is a Sell
* MoonLake Immunotherapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.